' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

SCHALLMOSER KATHARINA
Universitätsinstitut für Transfusionsmedizin
Zentrum für Querschnitt- und Geweberegeneration Salzburg

Publikationen | Forscherprofil

209 Publikationen

2018

Beiträge in Fachzeitschriften

Identification of the Human Skeletal Stem Cell.
Chan, CKF; Gulati, GS; Sinha, R; Tompkins, JV; Lopez, M; Carter, AC; Ransom, RC; Reinisch, A; Wearda, T; Murphy, M; Brewer, RE; Koepke, LS; Marecic, O; Manjunath, A; Seo, EY; Leavitt, T; Lu, WJ; Nguyen, A; Conley, SD; Salhotra, A; Ambrosi, TH; Borrelli, MR; Siebel, T; Chan, K; Schallmoser, K; Seita, J; Sahoo, D; Goodnough, H; Bishop, J; Gardner, M; Majeti, R; Wan, DC; Goodman, S; Weissman, IL; Chang, HY; Longaker, MT;
Cell. 2018; 175(1): 43-56.e21.
Originalarbeiten (Zeitschrift)
Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells
Oeller, M; Laner-Plamberger, S; Hochmann, S; Ketterl, N; Feichtner, M; Brachtl, G; Hochreiter, A; Scharler, C; Bieler, L; Romanelli, P; Couillard-Despres, S; Russe, E; Schallmoser, K; Strunk, D
THERANOSTICS. 2018; 8(5): 1421-1434.
Originalarbeiten (Zeitschrift)
International Forum on GMP-grade human platelet lysate for cell propagation.
Strunk, D; Lozano, M; Marks, DC; Loh, YS; Gstraunthaler, G; Schennach, H; Rohde, E; Laner-Plamberger, S; Öller, M; Nystedt, J; Lotfi, R; Rojewski, M; Schrezenmeier, H; Bieback, K; Schäfer, R; Bakchoul, T; Waidmann, M; Jonsdottir-Buch, SM; Montazeri, H; Sigurjonsson, OE; Iudicone, P; Fioravanti, D; Pierelli, L; Introna, M; Capelli, C; Falanga, A; Takanashi, M; López-Villar, O; Burnouf, T; Reems, JA; Pierce, J; Preslar, AM; Schallmoser, K;
Vox Sang. 2018; 113(1):e1-e25
Letter
International Forum on GMP-grade human platelet lysate for cell propagation: summary.
Strunk, D; Lozano, M; Marks, DC; Loh, YS; Gstraunthaler, G; Schennach, H; Rohde, E; Laner-Plamberger, S; Öller, M; Nystedt, J; Lotfi, R; Rojewski, M; Schrezenmeier, H; Bieback, K; Schäfer, R; Bakchoul, T; Waidmann, M; Jonsdottir-Buch, SM; Montazeri, H; Sigurjonsson, OE; Iudicone, P; Fioravanti, D; Pierelli, L; Introna, M; Capelli, C; Falanga, A; Takanashi, M; Lόpez-Villar, O; Burnouf, T; Reems, JA; Pierce, J; Preslar, AM; Schallmoser, K;
Vox Sang. 2018; 113(1):80-87
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

PLATELET DERIVED FACTORS IMPAIR TROPHOBLAST DIFFERENTIATION VIA ACTIVATION OF SMAD3 SIGNALING
Forstner, D; Maninger, S; Nonn, O; Moser, G; Leitinger, G; Pritz, E; Schallmoser, K; Siwetz, M; Marsche, G; Heinemann, A; Hoch, D; Desoye, G; Huppertz, B; Gauster, M
PLACENTA. 2018; 69: E88-E88.
Abstracts (Zeitschrift)
Influence of Heparin on Gene Expression of Stromal Cells Derived from Different Tissues
Laner-Plamberger, S; Oeller, M; Kalathur, R; Poupardin, R; Hochmann, S; Brachtl, G; Pachler, K; Kreutzer, C; Strunk, D; Rohde, E; Schallmoser, K
TRANSFUSION. 2018; 58: 66A-67A.
Abstracts (Zeitschrift)
Plasma Rotational Thrombelastometry for Evaluation of Hemocompatibility of Human Umbilical Cord Derived Stromal Cells
M. Oeller, S. Laner-Plamberger, G. Brachtl, E. Rohde, D. Strunk & K. Schallmoser
Transfusion. 2018; 58: 68A-69A.-AABB Annual Meeting; 13.-16.10.2018; Boston.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Towards better understanding of extracellular vesicle-mediated stroma-leukemia crosstalk in the bone marrow niche.
Girgis, R; Raninger, A; Hochreiter, A; Obermayer, A; Schallmoser, K; Brachtl, G; Wolf, M; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
26th Annual Congress of the ESGCT; 16.-19.10.2018; Lausanne. 2018.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
Development of an iPSC-mediated strategy for skin regeneration.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
2018 ESDR Future Leaders Academy; 03.-05.10.2018; Budapest. 2018.
Development of an iPSC-mediated strategy for skin regeneration.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of immunosuppressive iPSC-derived stromal cells for tissue regeneration.
Peking, P; Scharler, C; Ketterl, N; Hochreiter, A; Jürchott, K; Höfler, M; Brachtl, G; Wimmer, M; Wolf, M; Hochmann, S; Schallmoser, K; Volk, H-D; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
NO IDENTICAL STROMAL CELLS: TRANSCRIPTOMIC META-ANALYSIS HIGHLIGHTS DIFFERENCES BETWEEN BONE-MARROW-DERIVED MESENCHYMAL STROMAL/PROGENITOR CELLS AND OTHER STROMAL CELL SOURCES.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
NO IDENTICAL STROMAL CELLS: TRANSCRIPTOMIC META-ANALYSIS HIGHLIGHTS DIFFERENCES BETWEEN BONE-MARROW-DERIVED MESENCHYMAL STROMAL/PROGENITOR CELLS AND OTHER STROMAL CELL SOURCES.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Placental stromal cell-derived extracellular vesicles display immunomodulatory capacity and pro-angiogenic function.
Wolf, M; Vári, B; Raninger, A; Obermayer, A; Poupardin, R; Schallmoser, K; Ofir, R; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Placental stromal cell-derived extracellular vesicles display immunomodulatory capacity and pro-angiogenic function.
Wolf, M; Vári, B; Raninger, A; Obermayer, A; Poupardin, R; Schallmoser, K; Ofir, R; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
Placental stromal cell-derived extracellular vesicles display immunomodulatory capacity and pro-angiogenic function.
Wolf, M; Vári, B; Raninger, A; Obermayer, A; Poupardin, R; Schallmoser, K; Ofir, R; Strunk, D
26th Annual Congress of the ESGCT; 16.-19.10.2018; Lausanne. 2018.

2017

Beiträge in Fachzeitschriften

Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.
Gimona, M; Pachler, K; Laner-Plamberger, S; Schallmoser, K; Rohde, E;
Int J Mol Sci. 2017; 18(6):
Originalarbeiten (Zeitschrift)
An alternative mini buffy coat preparation method for adult patients with extracorporeal photopheresis contraindications.
Grabmer, C; Schlager, S; Mayer, G; Streif, D; Lener, T; Schallmoser, K; Rohde, E;
J Clin Apher. 2017; 32(1): 12-15.
Originalarbeiten (Zeitschrift)
A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles.
Pachler, K; Lener, T; Streif, D; Dunai, ZA; Desgeorges, A; Feichtner, M; Öller, M; Schallmoser, K; Rohde, E; Gimona, M;
Cytotherapy. 2017; 19(4): 458-472.
Originalarbeiten (Zeitschrift)
Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice.
Reinisch, A; Hernandez, DC; Schallmoser, K; Majeti, R;
Nat Protoc. 2017; 12(10): 2169-2188.
Originalarbeiten (Zeitschrift)
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.
Sheffield, NC; Pierron, G; Klughammer, J; Datlinger, P; Schönegger, A; Schuster, M; Hadler, J; Surdez, D; Guillemot, D; Lapouble, E; Freneaux, P; Champigneulle, J; Bouvier, R; Walder, D; Ambros, IM; Hutter, C; Sorz, E; Amaral, AT; de Álava, E; Schallmoser, K; Strunk, D; Rinner, B; Liegl-Atzwanger, B; Huppertz, B; Leithner, A; de Pinieux, G; Terrier, P; Laurence, V; Michon, J; Ladenstein, R; Holter, W; Windhager, R; Dirksen, U; Ambros, PF; Delattre, O; Kovar, H; Bock, C; Tomazou, EM;
Nat Med. 2017; 23(3): 386-395.
Originalarbeiten (Zeitschrift)
Stromal Cells Act as Guardians for Endothelial Progenitors by Reducing Their Immunogenicity After Co-Transplantation.
Souidi, N; Stolk, M; Rudeck, J; Strunk, D; Schallmoser, K; Volk, HD; Seifert, M;
Stem Cells. 2017; 35(5): 1233-1245.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Regenerative potential of periosteum-derived stromal cells
Brachtl, G; Hochreiter, A; Hochmann, S; Mittermeir, M; Raninger, A; Schallmoser, K; Wittig, J; Gaggl, A; Strunk, D
Human Gene Therapy. 2017; 28: A89-A90.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Human Platelet Lysate Modifications Affect Mesenchymal Stromal Cell Biology Depending on Cell Origin
Laner-Plamberger, S; Öller, M; Brachtl, G; Strunk, D; Hartl, A; Pachler, K; Feichtner, M; Hauser-Kronberger, C; Wiedemann, H; Rohde, E; Schallmoser, K
Vox Sanguinis. 2017; 112(1):285-286.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Heparin Changes the Gene Expression Profile of Mesenchymal Stem/Progenitor Cells
Laner-Plamberger, S; Öller, M; Kalathur, R; Strunk, D; Feichtner, M; Pachler, K; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
Vox Sanguinis. 2017; 112(1):66-66.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Heparin affects gene expression of mesenchymal stromal cells in a source-dependent manner
Laner-Plamberger, S; Oller, M; Kalathur, R; Strunk, D; Pachler, K; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
TRANSFUS MED HEMOTH. 2017; 44: 80-81.
Abstracts (Zeitschrift)
Heparin affects Gene Expression of Mesenchymal Stromal Cells in a Source-dependent Manner
Laner-Plamberger, S; Öller, M; Kalathur, R; Strunk, D; Pachler, K; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
Transfusion Medicine and Hemotherapy. 2017; 44(Suppl.1):p.80--50.Jahrestagung der DGTI; 24.-27.10.2017; Köln.
Abstracts (Zeitschrift)
Hemocompatibility of stromal cells depends on tissue factor expression and is influenced by organ origin and culture conditions
Oeller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, ZA; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
TRANSFUS MED HEMOTH. 2017; 44: 74-74.
Abstracts (Zeitschrift)
Selection of tissue factor-deficient bone marrow stromal cell transplants as a novel strategy to improve therapeutic applicability
Oeller, M; Laner-Plamberger, S; Ketterl, N; Feichtner, M; Raninger, A; Hochreiter, A; Brachtl, G; Dunai, ZA; Russe, E; Schulte, M; Rohde, E; Schallmoser, K; Strunk, D
Human Gene Therapy. 2017; 28: A97-A98.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Tissue Factor Expression and Hemocompatibility of Stromal Cells Depend on Organ Origin and Culture Conditions
Öller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, Z; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
Vox Sanguinis. 2017; 112(1):65-66.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Hemocompatibility of stromal cells depends on tissue factor expression and is influenced by organ origin and culture
Öller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, ZA; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2017; 44(Suppl.1):p.74--50.Jahrestagung der DGTI; 24.-27.10.2017; Köln.
Abstracts (Zeitschrift)
Production and quality control of platelet lysates worldwide-an approach towards GMP-grade manufacturing
Schallmoser, K
TRANSFUS MED HEMOTH. 2017; 44: 29-29.
Abstracts (Zeitschrift)
Production and quality control of platelet lysates worldwide - an approach towards GMP-grade manufacturing
Schallmoser, K
Transfusion Medicine and Hemotherapy. 2017; 44(Suppl. 1):p.75--50. Jahrestagung der DGTI; 24.-27.10.2017; Köln.
Abstracts (Zeitschrift)
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identifies key immunomodulatory pathways.
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk, D
Human Gene Therapy. 2017; 28: A83-A84.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Selection of tissue factor-deficient bone marrow stromal cell transplants as a novel strategy to improve therapeutic applicability
Öller, M; Laner-Plamberger, S; Ketterl, N; Feichtner, M; Raninger, A; Hochreiter, A; Brachtl, G; Dunai, ZA; Russe, E; Schulte, M; Rohde, E; Schallmoser, K; Strunk D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
GMP-grade manufacturing of Human Platelet Lysate - What do we have to consider?
Schallmoser, K
ISCT; 03.-06.05.2017; London. 2017.
Praktische Relevanz thrombozytärer Antikörper
Schallmoser, K
Jahrestagung der ÖGBT; 22.-24.05.2017; Schloss Seggauberg bei Leibnitz. 2017.
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identifies key immunomodulatory pathways
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.

2016

Beiträge in Fachzeitschriften

Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?
Burnouf, T; Strunk, D; Koh, MB; Schallmoser, K;
Biomaterials. 2016; 76: 371-387.
Übersichtsarbeiten
A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.
Reinisch, A; Thomas, D; Corces, MR; Zhang, X; Gratzinger, D; Hong, WJ; Schallmoser, K; Strunk, D; Majeti, R;
Nat Med. 2016; 22(7): 812-821.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

GMP-Compliant Production of Pooled Human Platelet Lysate – Setting Standards for Xeno-free Cell Propagation
Feichtner, M; Öller, M; Laner-Plamberger, S; Wiedemann, H; Rohde, E; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2016; 43(Suppl. 1):73--49. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie ; 07.-10.09.2016; Nürnberg.
Abstracts (Zeitschrift)
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
HUM GENE THER. 2016; 27(11): A65-A65.
Abstracts (Zeitschrift)
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs)
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
HUM GENE THER. 2016; 27(11): A64-A65.
Abstracts (Zeitschrift)
Influence of heparin on the genomic profile of human mesenchymal stromal/progenitor cells
Laner-Plamberger, S; Oller, M; Kalathur, R; Brachtl, G; Strunk, D; Feichtner, M; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
HUM GENE THER. 2016; 27(11): A61-A61.
Abstracts (Zeitschrift)
Efficient expansion of mesenchymal stem/progenitor cells supported by fibrinogen-depleted pooled human platelet lysate
Oller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
HUM GENE THER. 2016; 27(11): A63-A64.
Abstracts (Zeitschrift)
Fibrinogen-Depleted Pooled Human Platelet Lysate for Efficient Expansion of Mesenchymal Stromal Cells
Öller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
Vox Sanguinis. 2016; 111(Suppl. 1):285--34th International Congress of the ISBT ; 03.-08.09.2016; Dubai.
Abstracts (Zeitschrift)
Efficient Expansion of Mesenchymal Stromal Cells by Fibrinogen-Depleted Pooled Human Platelet Lysate
Öller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2016; 43(Suppl.1):71--49. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie ; 07.-10.09.2016; Nürnberg.
Abstracts (Zeitschrift)
Platelets for Regenerative Medicine - What about Evidence?
Schallmoser, K
Vox Sanguinis. 2016; 111(Suppl. 1):38-39.-34th International Congress of the ISBT ; 03.-08.09.2016; Dubai .
Abstracts (Zeitschrift)
Stepwise maturation of human iPS cells into clonogenic immunosuppressive mesenchymal stem/progenitor cells
Scharler, C; Ketterl, N; Hofler, M; Brachtl, G; Schallmoser, K; Strunk, D
HUM GENE THER. 2016; 27(11): A64-A64.
Abstracts (Zeitschrift)
DNA methylation mapping and computational modeling in a large Ewing sarcoma cohort identifies principles of tumor heterogeneity and their impact on clinical phenotypes
Sheffield, NC; Tirode, F; Grossetete-Lalami, S; Datlinger, P; Schonegger, A; Hadler, J; Walder, D; Ambros, IM; Amaral, AT; de Alava, E; Schallmoser, K; Strunk, D; Rinner, B; Liegl-Atzwanger, B; Huppertz, B; Leithner, A; Dirksen, U; Ambros, P; Delattre, O; Kovar, H; Bock, C; Tomazou, EM
CANCER RES. 2016; 76:
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Effect of different cell culture conditions on the growth and clonogenicity of MSPCs.
Brachtl, G; Raninger, A; Hochreiter, A; Schäfer, R; Schallmoser, K; Strunk, D
PMU Science Day; 24.06.2016; Salzburg. 2016.
Effect of different cell culture conditions on the growth and clonogenicity of MSPCs.
Brachtl, G; Raninger, A; Hochreiter, A; Schäfer, R; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Understanding the molecular landscape of human BM-derived MSPCs through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
PMU Science Day; 24.06.2016; Salzburg. 2016.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Daheron, L; Brachtl, G; Schallmoser, K; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Daheron, L; Brachtl, G; Schallmoser, K; Strunk, D
3rd PACT-Symposium: Designer Cells Go Clinic; 23.-24.09.2016; Wien. 2016.

2015

Beiträge in Fachzeitschriften

Iron depletion with a novel apheresis system in patients with hemochromatosis.
Grabmer, C; Schmid, D; Mayer, G; Aigner, E; Wagner, A; Streif, D; Schallmoser, K; Rohde, E;
Transfusion. 2015; 55(5):996-1000
Originalarbeiten (Zeitschrift)
Lesion-induced accumulation of platelets promotes survival of adult neural stem / progenitor cells.
Kazanis, I; Feichtner, M; Lange, S; Rotheneichner, P; Hainzl, S; Öller, M; Schallmoser, K; Rohde, E; Reitsamer, HA; Couillard-Despres, S; Bauer, HC; Franklin, RJ; Aigner, L; Rivera, FJ;
Exp Neurol. 2015; 269: 75-89.
Originalarbeiten (Zeitschrift)
A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance.
Ketterl, N; Brachtl, G; Schuh, C; Bieback, K; Schallmoser, K; Reinisch, A; Strunk, D;
Stem Cell Res Ther. 2015; 6: 236
Originalarbeiten (Zeitschrift)
Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate.
Laner-Plamberger, S; Lener, T; Schmid, D; Streif, DA; Salzer, T; Öller, M; Hauser-Kronberger, C; Fischer, T; Jacobs, VR; Schallmoser, K; Gimona, M; Rohde, E;
J Transl Med. 2015; 13(1): 354
Originalarbeiten (Zeitschrift)
Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.
Lener, T; Gimona, M; Aigner, L; Börger, V; Buzas, E; Camussi, G; Chaput, N; Chatterjee, D; Court, FA; Del Portillo, HA; O"Driscoll, L; Fais, S; Falcon-Perez, JM; Felderhoff-Mueser, U; Fraile, L; Gho, YS; Görgens, A; Gupta, RC; Hendrix, A; Hermann, DM; Hill, AF; Hochberg, F; Horn, PA; de Kleijn, D; Kordelas, L; Kramer, BW; Krämer-Albers, EM; Laner-Plamberger, S; Laitinen, S; Leonardi, T; Lorenowicz, MJ; Lim, SK; Lötvall, J; Maguire, CA; Marcilla, A; Nazarenko, I; Ochiya, T; Patel, T; Pedersen, S; Pocsfalvi, G; Pluchino, S; Quesenberry, P; Reischl, IG; Rivera, FJ; Sanzenbacher, R; Schallmoser, K; Slaper-Cortenbach, I; Strunk, D; Tonn, T; Vader, P; van Balkom, BW; Wauben, M; Andaloussi, SE; Théry, C; Rohde, E; Giebel, B;
J Extracell Vesicles. 2015; 4: 30087
Originalarbeiten (Zeitschrift)
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.
Reinisch, A; Etchart, N; Thomas, D; Hofmann, NA; Fruehwirth, M; Sinha, S; Chan, CK; Senarath-Yapa, K; Seo, EY; Wearda, T; Hartwig, UF; Beham-Schmid, C; Trajanoski, S; Lin, Q; Wagner, W; Dullin, C; Alves, F; Andreeff, M; Weissman, IL; Longaker, MT; Schallmoser, K; Majeti, R; Strunk, D;
Blood. 2015; 125(2): 249-260.
Originalarbeiten (Zeitschrift)
Platelet antibody analysis by three different tests.
Sareban, N; Macher, S; Drexler, C; Posch, U; Lanzer, G; Schallmoser, K;
J Clin Lab Anal. 2015; 29(3): 198-202.
Originalarbeiten (Zeitschrift)
T-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy.
Schmid, D; Grabmer, C; Streif, D; Lener, T; Schallmoser, K; Rohde, E;
Vox Sang. 2015; 108(1):82-88
Originalarbeiten (Zeitschrift)
Biological properties of extracellular vesicles and their physiological functions.
Yáñez-Mó, M; Siljander, PR; Andreu, Z; Zavec, AB; Borràs, FE; Buzas, EI; Buzas, K; Casal, E; Cappello, F; Carvalho, J; Colás, E; Cordeiro-da Silva, A; Fais, S; Falcon-Perez, JM; Ghobrial, IM; Giebel, B; Gimona, M; Graner, M; Gursel, I; Gursel, M; Heegaard, NH; Hendrix, A; Kierulf, P; Kokubun, K; Kosanovic, M; Kralj-Iglic, V; Krämer-Albers, EM; Laitinen, S; Lässer, C; Lener, T; Ligeti, E; Linē, A; Lipps, G; Llorente, A; Lötvall, J; Manček-Keber, M; Marcilla, A; Mittelbrunn, M; Nazarenko, I; Nolte-"t Hoen, EN; Nyman, TA; O"Driscoll, L; Olivan, M; Oliveira, C; Pállinger, É; Del Portillo, HA; Reventós, J; Rigau, M; Rohde, E; Sammar, M; Sánchez-Madrid, F; Santarém, N; Schallmoser, K; Ostenfeld, MS; Stoorvogel, W; Stukelj, R; Van der Grein, SG; Vasconcelos, MH; Wauben, MH; De Wever, O;
J Extracell Vesicles. 2015; 4: 27066
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

An alternative mini buffy coat preparation method for adult patients with extracorporeal photopheresis contraindications
Grabmer, C; Schlager, S; Mayer, G; Streif, D; Lener, T; Schallmoser, K; Rohde, E;
An alternative mini buffy coat preparation method for patients with extracorporeal photopheresis contraindications. 2015; -DGTI; 15.-18.09.2015; Basel.
Abstracts (Zeitschrift)
Modifications of human platelet lysate for efficient expansion of mesenchymal stromal cells without fibrinogen.
Öller, M: Feichtner, M; Dunai, ZA; Raninger, A; Laner-Plamberger, S; Lener, T; Streif, D; Gimona, M; Hartl, A; Bieback, K; Wiedemann, H; Rohde, E; Strunk, D; Schallmoser, K
Transfus Med Hemother 2015;42(suppl1):p.63. 2015; -48.Jahrestagung der DGTI (Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie e.V.); 15. -18. 09.2015; Basel.
Abstracts (Zeitschrift)
CNS lesion-induced accumulation of platelets promotes survival of adult SVZ-derived neural stem / progenitor cells
Rivera, F; Kazanis, I; Feichtner, M; Lange, S; Rotheneichner, P; Hainzl, S; Oller, M; Schallmoser, K; Rohde, E; Reitsamer, HA; Couillard-Despres, S; Bauer, HC; Franklin, RJM; Aigner, L
GLIA. 2015; 63: E403-E403.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Proliferation of umbilical cord derived mesenchymal stem cells is enhanced by heparin in the absence of platelet lysate-borne fibrinogen
Laner-Plamberger, S; Lener, T; Schmid, D; Streif, DA; Salzer, T; Öller, M; Hauser-Kronberger, C; Fischer, T; Jacobs, VR; Schallmoser, K; Gimona, M;, Rohde, E
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Efficient animal serum-free propagation of mesenchymal stem cells by using fibrinogen-depleted modifications of human platelet lysate.
Öller, M; Feichtner, M; Dunai, ZA; Raninger, A; Laner-Plamberger, S; Lener, T; Gimona, M; Hartl, A; Bieback, K; Rohde, E; Strunk, D; Schallmoser, K
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk D.
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Attenuation of alloimmunity to human Endothelial Colony Forming Cells (ECFC) by interaction with Mesenchymal Stem/Progenitor Cells (MSPC) from umbilical cord.
Souidi, N; Rudeck, J; Stolk, M; Schmitt-Knosalla, I; Schuh, C; Schallmoser, K; Strunk, D; Volk, H-D; Seifert, M
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.
Strunk, D; Schallmoser, K; Reinisch, A; Majeti, R
Keystone Symposium 2015 on Haematopoiesis; 22.-27.02.2015; Keystone, Colorado. 2015.

2014

Beiträge in Fachzeitschriften

Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.
Jacamo, R; Chen, Y; Wang, Z; Ma, W; Zhang, M; Spaeth, EL; Wang, Y; Battula, VL; Mak, PY; Schallmoser, K; Ruvolo, P; Schober, WD; Shpall, EJ; Nguyen, MH; Strunk, D; Bueso-Ramos, CE; Konoplev, S; Davis, RE; Konopleva, M; Andreeff, M;
Blood. 2014; 123(17): 2691-2702.
Originalarbeiten (Zeitschrift)
Therapeutic red blood cell exchange in a child with sickle cell anaemia using the Spectra Optia® apheresis system.
Sipurzynski-Budrass, S; Sovinz, P; Lanzer, G; Schallmoser, K;
Transfus Med. 2014; 24(3):184-186
Letter

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Analyzing the immune modulation potential of human mesenchymal stem/progenitor cells.
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014. ; 13.11.2014; Salzburg. 2014.
Predicting and optimizing the immune modulation potential of human mesenchymal stem/progenitor cells.
Ketterl, N; Brachtl, G, Schuh, C; Schallmoser, K; Strunk, D
2nd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.

2013

Beiträge in Fachzeitschriften

Donor selection and release criteria of cellular therapy products.
Eichler, H; Schrezenmeier, H; Schallmoser, K; Strunk, D; Nystedt, J; Kaartinen, T; Korhonen, M; Fleury-Cappellesso, S; Sensebé, L; Bönig, H; Rebulla, P; Giordano, R; Lecchi, L; Takanashi, M; Watt, SM; Austin, EB; Guttridge, M; McLaughlin, LS; Panzer, S; Reesink, HW;
Vox Sang. 2013; 104(1): 67-91.
Originalarbeiten (Zeitschrift)
Tri-lineage potential of intraoral tissue-derived mesenchymal stromal cells.
Lohberger, B; Payer, M; Rinner, B; Kaltenegger, H; Wolf, E; Schallmoser, K; Strunk, D; Rohde, E; Berghold, A; Pekovits, K; Wildburger, A; Leithner, A; Windhager, R; Jakse, N;
J Craniomaxillofac Surg. 2013; 41(2):110-118
Originalarbeiten (Zeitschrift)
Identification of an Effective Early Signaling Signature during Neo-Vasculogenesis In Vivo by Ex Vivo Proteomic Profiling
Rohban, R; Reinisch, A; Etchart, N; Schallmoser, K; Hofmann, NA; Szoke, K; Brinchmann, JE; Rad, EB; Rohde, E; Strunk, D
PLOS ONE. 2013; 8(6): e66909
Originalarbeiten (Zeitschrift)
Generation of a pool of human platelet lysate and efficient use in cell culture.
Schallmoser, K; Strunk, D;
Methods Mol Biol. 2013; 946:349-362
Originalarbeiten (Zeitschrift)
A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies.
Warnke, PH; Humpe, A; Strunk, D; Stephens, S; Warnke, F; Wiltfang, J; Schallmoser, K; Alamein, M; Bourke, R; Heiner, P; Liu, Q;
J Craniomaxillofac Surg. 2013; 41(2):153-161
Originalarbeiten (Zeitschrift)

2012

Beiträge in Fachzeitschriften

Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.
Ansari, M; Strunk, D; Schallmoser, K; Delcò, C; Rougemont, AL; Moll, S; Villard, J; Gumy-Pause, F; Chalandon, Y; Parvex, P; Passweg, J; Ozsahin, H; Kindler, V;
Pediatr Transplant. 2012; 16(2):131-136
Originalarbeiten (Zeitschrift)
Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo.
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Rohban, R; Etchart, N; Fruehwirth, M; Beham-Schmid, C; Andreeff, M; Strunk, D;
PLoS One. 2012; 7(9):e44468
Originalarbeiten (Zeitschrift)
Influence of multicomponent apheresis on donors" haematological and coagulation parameters, iron storage and platelet function.
Macher, S; Sipurzynski-Budraβ, S; Rosskopf, K; Semmelrock, M; Prüller, F; Griesbacher, A; Lanzer, G; Schallmoser, K;
Vox Sang. 2012; 103(3):194-200
Originalarbeiten (Zeitschrift)
Reticulocyte hemoglobin content allows early and reliable detection of functional iron deficiency in blood donors.
Semmelrock, MJ; Raggam, RB; Amrein, K; Avian, A; Schallmoser, K; Lanzer, G; Semmelrock, HJ; Prueller, F; Berghold, A; Rohde, E;
CLIN CHIM ACTA. 2012; 413(7-8): 67-82.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Platelet-derived factors preserve human mesenchymal cell stemness and promote endochondral bone and marrow niche formation via PDGF-receptor signalling
Etchart, N; Reinisch, A; Ortner, A; Fruhwirth, M; Hofmann, N; Rohban, R; Url, C; Schallmoser, K; Beham-Schmid, C; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S49-S50.
Abstracts (Zeitschrift)
Collagen receptor-mediated mechanochemical signalling modulates human pro-angiogenic mesenchymal stem/progenitor cells during neovascularisation
Gimona, M; Rohban, R; Lener, T; Oller, M; Schallmoser, K; Strunk, D; Rohde, E
BONE MARROW TRANSPL. 2012; 47: S317-S317.
Abstracts (Zeitschrift)
Collagen Receptor-Mediated Mechanochemical Signaling Contributes to Human Pro-Angiogenic Mesenchymal Stem/Progenitor Cell-Induced Neo-Vasculogenesis
Gimona, M; Rohban, R; Lener, T; Peckl-Schmid, D; Oeller, M; Schallmoser, K; Strunk, D; Rohde, E
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Therapeutic neo-vasculogenesis in vivo is promoted by oxygen sensing mesenchymal stem/progenitor cells
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Etchart, N; Schallmoser, K; Fruehwirth, M; Rohban, R; Beham-Schmid, C; Andreeff, M; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S319-S320.
Abstracts (Zeitschrift)
Single Center Experience with the Nanoparticle-Based Flow Immunoassay for Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
Macher, S; Sareban, N; Drexler, C; Lanzer, G; Schallmoser, K
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Organotypic Epigenetic Signature Predicts Bone and Marrow Niche Forming Capacity of Stromal Progenitors in a Novel Mouse Model in Vivo
Reinisch, A; Etchart, N; Hofmann, NA; Fruhwirth, M; Ortner, A; Thaler, D; Feilhauer, B; Hartwig, UF; Beham-Schmid, C; Trajanosky, S; Wagner, W; Alves, F; Schallmoser, K; Andreeff, M; Strunk, D
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Bone and haematopoietic niche formation is predetermined by a specific epigenetic signature
Reinisch, A; Etchart, N; Hofmann, NA; Fruhwirth, M; Thaler, D; Feilhauer, B; Ortner, A; Beham-Schmid, C; Trajanoski, S; Wagner, W; Schallmoser, K; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S48-S49.
Abstracts (Zeitschrift)
Early in vivo signalling signature during human stem/progenitor cell-derived neo-vasculogenesis
Rohban, R; Etchart, N; Reinisch, A; Hofmann, N; Thaler, D; Feilhauer, B; Dacheva, M; Schallmoser, K; Rohde, E; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S49-S49.
Abstracts (Zeitschrift)
Maintenance of Osteogenic Differentiation Capacity of MSPC Despite Amplified Proliferation Under Elevated Oxgen Conditions
Schallmoser, K; Hofmann, NA; Reinisch, A; Ortner, A; Url, C; Etchart, N; Joussen, S; Wagner, W; Strunk, D
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Elevated oxygen environment boosts MSPC proliferation without senescence aggravation
Schallmoser, K; Ortner, A; Hofmann, NA; Etchart, N; Joussen, S; Url, C; Wagner, W; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S319-S319.
Abstracts (Zeitschrift)
Therapeutic Red Blood Cell Exchange in Sickle Cell Anaemia Using the Spectra Optia (R) Apheresis System
Sipurzynski-Budraa, S; Sovinz, P; Lanzer, G; Schallmoser, K
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Evaluating immunogenicity of human endothelial colony forming cells for application in cell-based therapies
Souidi, N; Schallmoser, K; Strunk, D; Schmidt-Lucke, C; Volk, HD; Seifert, M
J TISSUE ENG REGEN M. 2012; 6: 247-247.
Abstracts (Zeitschrift)
Xeno-free culturing of human muscle precursor cells (MPC) for clinical application
Zouraq, FA; Salemi, S; Largo, RA; Schallmoser, K; Strunk, D; Susler, T; Eberli, D
J TISSUE ENG REGEN M. 2012; 6: 132-132.
Abstracts (Zeitschrift)

Originalbeiträge in Sammelwerk (Buchbeitrag)

Animal Protein-free Expansion of Human Mesenchymal Stem/progenitor Cells.
Schallmoser, K; Etchart, N; Strunk, D; Rohde, E;
In: Allen, DS; Strunk, D (Ed.) editors(s). Regenerative Therapy Using Blood-Derived Stem cells.. p. 53-70.

2011

Beiträge in Fachzeitschriften

Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate.
Flemming, A; Schallmoser, K; Strunk, D; Stolk, M; Volk, HD; Seifert, M;
J Clin Immunol. 2011; 31(6): 1143-1156.
Originalarbeiten (Zeitschrift)
Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D;
CYTOTHERAPY. 2011; 13(4): 503-512.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Human platelet-derived factors maintain a bone and marrow niche-competent function of mesenchymal stem/progenitor cells
Etchart, N; Reinisch, A; Gungl, D; Hofmann, NA; Rohban, R; Ortner, A; Rankl, J; Hofmeister, A; Beham-Schmid, C; Schallmoser, K; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S303-S303.
Abstracts (Zeitschrift)
Platelet-Derived Factors Allow Human Mesenchymal Stem Cells to Spontaneously Undergo Endochondral Bone Differentiation and Provide Bone Marrow Support in a Xenogenic In Vivo Model
Etchart, N; Reinisch, A; Ortner, A; Fruhwirth, M; Rohban, R; Url, C; Schallmoser, K; Beham-Schmid, C; Strunk, D
BLOOD. 2011; 118(21): 583-584.
Abstracts (Zeitschrift)
Neo-Vasculogenesis In Vivo Is Facilitated by Oxygen Sensing Mesenchymal Stem and Pogenitor Cells
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Fruewirth, M; Diwoky, C; Rohban, R; Beham-Schmid, C; Andreeff, M; Strunk, D
BLOOD. 2011; 118(21): 319-319.
Abstracts (Zeitschrift)
Vascular regeneration in vivo is promoted by oxygen sensing mesenchymal stem and progenitor cells
Hofmann, NA; Reinisch, A; Ortner, A; Etchart, N; Schallmoser, K; Absenger, M; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S302-S302.
Abstracts (Zeitschrift)
Unexpected somatic restriction of mesenchymal stem and progenitor cells after transplantation in vivo
Reinisch, A; Etchart, N; Hofmann, NA; Gungl, D; Ortner, A; Rankl, J; Beham-Schmid, C; Schallmoser, K; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S302-S303.
Abstracts (Zeitschrift)
Dissociation of In Vivo and in Vitro Differentiation Capacity of Human Mesenchymal Stem Cells Is Reflected by a Tissue Specific Epigenetic Memory
Reinsch, A; Liechtenstein, N; Hofmann, NA; Ortner, A; Fruhwirth, M; Schallmoser, K; Beham-Schmid, C; Strunk, D
BLOOD. 2011; 118(21): 1027-1028.
Abstracts (Zeitschrift)

2010

Beiträge in Fachzeitschriften

Function and activation state of platelets in vitro depend on apheresis modality.
Macher, S; Sipurzynski-Budrass, S; Rosskopf, K; Rohde, E; Griesbacher, A; Groselj-Strele, A; Lanzer, G; Schallmoser, K;
VOX SANG. 2010; 99(4): 332-340.
Originalarbeiten (Zeitschrift)
Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Strunk, D; Wagner, W;
HAEMATOL-HEMATOL J. 2010; 95(6): 86-74.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

HYPOXIA MAINTAINS STEMNESS OF ENDOTHELIAL PROGENITOR CELLS
Hofmann, N; Reinisch, A; Schallmoser, K; Rohde, E; Absenger, M; Birner-Gruenberger, R; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 97-97.
Abstracts (Zeitschrift)
Oxygen Sensing of Mesenchymal Stem and Progenitor Cells Facilitates Neo-Vasculogenesis In Vivo.
Hofmann, NA; Reinisch, A; Ortner, A; Schallmoser, K; Rohde, E; Absenger, M; Birner-Gruenberger, R; Strunk, D
BLOOD. 2010; 116(21): 1750-1750.
Abstracts (Zeitschrift)
Hypoxia maintains stemness of somatic endothelial colony forming progenitor cells
Hofmann, NA; Reinisch, A; Schallmoser, K; Rohde, E; Chatterjee, S; Absenger, M; Birner-Gruenberger, R; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S279-S279.
Abstracts (Zeitschrift)
HIGH ACTIVATION STATE OF APHERESIS PLATELETS AFTER LOW VOLUME CENTRIFUGATION DURING MULTICOMPONENT COLLECTION
Macher, S; Sipurzynski, S; Rosskopf, K; Rohde, E; Groselj-Strele, A; Griesbacher, A; Lanzer, G; Schallmoser, K
HAEMATOL-HEMATOL J. 2010; 95: 436-436.
Abstracts (Zeitschrift)
HIGHER ACTIVATION STATE OF PLATELETS AFTER APHERESIS: EVIDENCE FOR AN IMPACT OF LOW VOLUME CENTRIFUGATION
Macher, S; Sipurzynski, S; Rosskopf, K; Rohde, E; Groselj-Strele, A; Griesbacher, A; Lanzer, G; Schallmoser, K
VOX SANG. 2010; 99: 168-168.
Abstracts (Zeitschrift)
High ex vivo activation state of platelets after apheresis due to low-volume centrifugation during multicomponent collection
Macher, S; Sipurzynski, S; Rosskopf, K; Rohde, E; Groselj-Strele, A; Griesbacher, A; Lanzer, G; Schallmoser, K
BONE MARROW TRANSPL. 2010; 45: S382-S383.
Abstracts (Zeitschrift)
Human Vascular Progenitor Cells Can Guide Mesodermal Lineage Choice of Mesenchymal Stem and Progenitor Cells After Co-Transplantation In Vivo
Reinisch, A; Etchart, N; Hofmann, NA; Ortner, A; Rohde, E; Schallmoser, K; Beham-Schmid, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
BLOOD. 2010; 116(21): 414-415.
Abstracts (Zeitschrift)
STABLE VESSEL GENERATION TROUGH APPLICATION OF BLOOD-DERIVED ENDOTHELIAL COLONY FORMING PROGENITOR CELLS (ECFCS) AND MESENCHYMAL STROMAL/STEM CELLS (MSCS)
Reinisch, A; Hofmann, N; Obenauf, A; Karl, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 208-208.
Abstracts (Zeitschrift)
Sustained vessel formation through co-transplantation of endothelial colony-forming progenitor cells with mesenchymal stromal cells
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S52-S52.
Abstracts (Zeitschrift)
BLOOD AND MARROW-DERIVED PROGENITORS ARE SUSCEPTIBLE TO MAPK P38-DEPENDENT FOAM CELL INDUCTION
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, N; Pfeifer, T; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 436-436.
Abstracts (Zeitschrift)
THERAPEUTIC ANGIOGENESIS WITH CELLULAR THERAPY: PRO-ANGIOGENIC INDUCTION OF MYELOID CELLS CAN FAVOR MAPK P38-DEPENDENT FOAM CELL DEVELOPMENT
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Lanzer, G; Strunk, D
VOX SANG. 2010; 99: 20-20.
Abstracts (Zeitschrift)
MAPK p38-dependent foam cell formation of myeloid cells after pro-angiogenic induction as a risk factor of therapeutic angiogenesis
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Lanzer, G; Linkesch, W; Kratky, D; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S283-S283.
Abstracts (Zeitschrift)
SENESCENCE-ASSOCIATED GENE EXPRESSION CHANGES IN MESENCHYMAL STROMAL/STEM CELLS
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, A; Reinisch, A; Horn, P; Ho, A; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 98-98.
Abstracts (Zeitschrift)
Replicative senescence-associated gene expression changes in mesenchymal stromal cells
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Hom, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S281-S281.
Abstracts (Zeitschrift)
SIMILARITY OF REPLICATIVE SENESCENCE-ASSOCIATED GENE EXPRESSION CHANGES IN MESENCHYMAL STROMAL CELLS UNDER VARIOUS CULTURE CONDITIONS
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
VOX SANG. 2010; 99: 481-482.
Abstracts (Zeitschrift)
Genomic Stability of Mesenchymal Stromal/Stem Cells After Long-Term Culture
Schallmoser, K; Rohde, E; Obenauf, AC; Reinisch, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
TRANSFUSION. 2010; 50: 24A-24A.
Abstracts (Zeitschrift)
GENOMIC STABILITY IN LONG-TERM CULTURED MESENCHYMAL STROMAL/STEM CELLS
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 97-97.
Abstracts (Zeitschrift)
Alteration of genomic stability in long-term cultured mesenchymal stromal cells
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S280-S280.
Abstracts (Zeitschrift)
Combined action of endothelial and mesenchymal niche cells to amplify haematopoietic progenitor expansion in a humanized system
Thaler, D; Fruthwirth, M; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Hartwig, U; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S53-S53.
Abstracts (Zeitschrift)

2009

Beiträge in Fachzeitschriften

Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
Bieback, K; Hecker, A; Kocaömer, A; Lannert, H; Schallmoser, K; Strunk, D; Klüter, H;
Stem Cells. 2009; 27(9): 233-241.
Originalarbeiten (Zeitschrift)
Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.
Reinisch, A; Hofmann, NA; Obenauf, AC; Kashofer, K; Rohde, E; Schallmoser, K; Flicker, K; Lanzer, G; Linkesch, W; Speicher, MR; Strunk, D;
Blood. 2009; 113(26): 6716-6725.
Originalarbeiten (Zeitschrift)
The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia?
Schallmoser, K; Drexler, C; Rohde, E; Strunk, D; Groselj-Strele, A; Lanzer, G; Kroll, H; Panzer, S;
J Thorac Cardiovasc Surg. 2009; 137(3): 781-783.
Editorials
Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells.
Schallmoser, K; Rohde, E; Bartmann, C; Obenauf, AC; Reinisch, A; Strunk, D;
Biomed Mater Eng. 2009; 19(4-5): 271-276.
Originalarbeiten (Zeitschrift)
Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures.
Schallmoser, K; Strunk, D;
J Vis Exp. 2009; (32):
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Contribution of endothelial and mesenchymal niche cells to haematopoietic progenitor expansion in a humanised system
Fruehwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S188-S189.
Abstracts (Zeitschrift)
HLA alloimmunization and unrelated hematopoietic stem cell transplantation - two case reports
Posch, U; Zinke-Cerwenka, W; Ulrich, S; Schallmoser, K; Drexler, C; Lanzer, G
TISSUE ANTIGENS. 2009; 73(5): 444-445.
Abstracts (Zeitschrift)
Vascular regeneration by adult blood-derived endothelial colony-forming cells expanded under animal serum-free conditions
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S19-S20.
Abstracts (Zeitschrift)
Pro-atherogenic risk of cellular therapy for vascular regeneration?
Rohde, E; Pfeifer, T; Schallmoser, K; Reinisch, A; Hofmann, NA; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S203-S204.
Abstracts (Zeitschrift)
Evidence for genomic stability of bone marrow-derived MSCS after large-scale expansion in a humanised system
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S187-S187.
Abstracts (Zeitschrift)

Beiträge in Sonstigen Zeitschriften

Blutplättchen stimulieren Stammzellen
Schallmoser, K
Krebshilfe. 2009. 4: 12-13.

2008

Beiträge in Fachzeitschriften

Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.
Bieback, K; Schallmoser, K; Klutera, H; Strunk, D
TRANSFUS MED HEMOTH. 2008; 35(4): 286-294.
Originalarbeiten (Zeitschrift)
Thrombin generation before and after multicomponent blood collection.
Cimenti, C; Sipurzynski, S; Gallistl, S; Rosenkranz, A; Hiden, M; Leschnik, B; Schallmoser, K; Lanzer, G; Muntean, WE;
Hamostaseologie. 2008; 28 Suppl 1: S73-S76.
Originalarbeiten (Zeitschrift)
Thrombin generation before and after multicomponent blood collection.
Cimenti, C; Sipurzynski, S; Gallistl, S; Rosenkranz, A; Hiden, M; Leschnik, B; Schallmoser, K; Lanzer, G; Muntean, WE;
Transfusion. 2008; 48(8):1584-1590
Originalarbeiten (Zeitschrift)
Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.
Schallmoser, K; Rohde, E; Reinisch, A; Bartmann, C; Thaler, D; Drexler, C; Obenauf, AC; Lanzer, G; Linkesch, W; Strunk, D;
Tissue Eng Part C Methods. 2008; 14(3):185-196
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Combined Action of Endothelial and Mesenchymal Niche Cells to Amplify Hematopoietic Progenitor Expansion in a Humanized System
Frohwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D
BLOOD. 2008; 112(11): 840-840.
Abstracts (Zeitschrift)
Human platelet-derived factors regulate gene expression profile and function of human multipotent mesenchymal stromal cells
Reinisch, A; Bartmann, C; Schallmoser, K; Rohde, E; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2008; 41: S128-S129.
Abstracts (Zeitschrift)
Molecular imaging of bone marrow stromal cells
Reinisch, A; Diwoky, C; Hofmann, N; Schallmoser, K; Linkesch, W; Stollberger, R; Strunk, D
BONE MARROW TRANSPL. 2008; 41: S432-S432.
Abstracts (Zeitschrift)
Excluding HIT Diagnosis by a Particle Gel Immunoassay
Schallmoser, K; Drexler, C; Rohde, E; Strunk, D; Groselj-Strele, A; Lanzer, G; Kroll, H; Panzer, S
BLOOD. 2008; 112(11): 1168-1168.
Abstracts (Zeitschrift)
Minimum requirements for fully humanised clinical scale propagation of multipotent mesenchymal stromal cells
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Speicher, M; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2008; 41: S314-S314.
Abstracts (Zeitschrift)
Genomic Stability and Safety of MSCs after Animal Serum-Free Humanized Clinical Scale Propagation
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2008; 112(11): 805-805.
Abstracts (Zeitschrift)

Originalbeiträge in Sammelwerk (Buchbeitrag)

GMP-Compliant Propagation of Human Multipotent Mesenchymal Stromal Cells
Rohde, E; Schallmoser, K; Bartmann, C; Reinisch, A;Strunk D
In: Gad, SC editors(s). Pharmaceutical Manufacturing Handbook: Regulations and Quality . John Wiley & Sons, Inc. ; p. 97-115.

2007

Beiträge in Fachzeitschriften

Two steps to functional mesenchymal stromal cells for clinical application.
Bartmann, C; Rohde, E; Schallmoser, K; Pürstner, P; Lanzer, G; Linkesch, W; Strunk, D;
Transfusion. 2007; 47(8): 1426-1435.
Originalarbeiten (Zeitschrift)
Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D;
Regen Med. 2007; 2(4):371-382
Originalarbeiten (Zeitschrift)
Immune cells mimic the morphology of endothelial progenitor colonies in vitro.
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D;
Stem Cells. 2007; 25(7):1746-1752
Originalarbeiten (Zeitschrift)
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.
Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Kashofer, K; Stadelmeyer, E; Drexler, C; Lanzer, G; Linkesch, W; Strunk, D;
Transfusion. 2007; 47(8):143-146
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Human platelet-derived factors induce differential gene expression in bone marrow mesenchymal stem cells
Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 318-318.
Abstracts (Zeitschrift)
Gene expression profiling of human multipotent mesenchymal stromal cells
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S51-S51.
Abstracts (Zeitschrift)
Clinical scale propagation of functional cord blood stem cells in a humanized system
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bielic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 318-318.
Abstracts (Zeitschrift)
Clinical scale expansion of human cord blood-derived multipotent stem cells in a new FBS-free system
Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S132-S133.
Abstracts (Zeitschrift)
Immune cells mimic endothelial progenitor colonies
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
TRANSFUSION. 2007; 47(3): 69A-69A.
Abstracts (Zeitschrift)
Immune cells mimic the morphology of endothelial progenitor colonies in vitro
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 315-315.
Abstracts (Zeitschrift)
Immune cells mimic endothelial progenitor colonies
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S123-S123.
Abstracts (Zeitschrift)
A novel system for highly efficient clinical scale propagation of human mesenchymal stem cells with human platelet lysate
Schallmoser, K; Bartmarm, C; Rohde, E; Reinisch, A; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 317-318.
Abstracts (Zeitschrift)
Detection of specific IGG antibodies in heparin-induced thrombocytopenia type II
Schallmoser, K; Drexler, C; Rohde, E; Groselj-Strele, A; Panzer, S; Lanzer, G
HAEMATOL-HEMATOL J. 2007; 92: 282-282.
Abstracts (Zeitschrift)
Two steps to clinical multipotent mesenchymal stromal cells with human platelet lysate
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Kashofer, K; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S110-S110.
Abstracts (Zeitschrift)
Animal serum-free clinical scale propagation of human MSC
Schallmoser, K; Reinisch, A; Bartmann, C; Rohde, E; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D
TRANSFUSION. 2007; 47(3): 28A-28A.
Abstracts (Zeitschrift)

2006

Beiträge in Fachzeitschriften

Delayed detectability of anti-HPA-3a by the MAIPA assay in a severe neonatal alloimmune thrombocytopenia, but successful transfusion of incompatible donor platelets: a case report.
Schallmoser, K; Kutschera, J; Macher, S; Ulrich, S; Eichler, P; Panzer, S; Lanzer, G;
Vox Sang. 2006; 91(2):181-183
Originalarbeiten (Zeitschrift)
Specificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: a relation to their history of thromboembolic disease.
Schallmoser, K; Rosin, C; Vormittag, R; Brunner, M; Dunkler, D; Pabinger, I; Panzer, S;
Lupus. 2006; 15(8):507-514
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Multicomponent apheresis with two different cell separators: Comparison of platelet function and metabolic parameters
Macher, S; Schallmoser, K; Sipurzynski, S; Rosskopf, K; Lanzer, G
TRANSFUSION. 2006; 46(9): 41A-41A.
Abstracts (Zeitschrift)
Human platelet-derived factors regulate mesenchymal stem cell gene expression.
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2006; 108(11): 142B-142B.
Abstracts (Zeitschrift)
Immune cells mimic endothelial progenitor colonies.
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
BLOOD. 2006; 108(11): 513A-513A.
Abstracts (Zeitschrift)
Specific IgG antibodies against Heparin/Platelet factor-4 complex in surgical and medical patients tested by ELISA and particle gel immunoassay
Schallmoser, K; Macher, S; Drexler, C; Panzer, S; Lanzer, G
TRANSFUSION. 2006; 46(9): 121A-121A.
Abstracts (Zeitschrift)
Activation markers and function of platelets collected by multicomponent apheresis with two different devices during seven days of storage
Schallmoser, K; Macher, S; Sipurzynski, S; Rosskopf, K; Lanzer, G
TRANSFUSION. 2006; 46(9): 30A-31A.
Abstracts (Zeitschrift)
Human mesenchymal stem cell therapy: Platelet lysate supports efficient preclinical expansion.
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2006; 108(11): 1042A-1042A.
Abstracts (Zeitschrift)
Automatic platelet concentrate preparation induces higher recovery of platelets
Schallmoser, K; Rosskopf, K; Macher, S; Stubenrauch, M; Lanzer, G
BONE MARROW TRANSPL. 2006; 37: S301-S302.
Abstracts (Zeitschrift)

2005

Beiträge in Fachzeitschriften

Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report.
Macher, S; Schallmoser, K; Staber, PB; Neumeister, P; Posch, U; Lanzer, G; Panzer, S;
Vox Sang. 2005; 89(4):257-260
Originalarbeiten (Zeitschrift)
The Fc gammaRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patients.
Schallmoser, K; Rosin, C; Knittelfelder, R; Sailer, T; Ulrich, S; Zoghlami, C; Lehr, S; Pabinger, I; Panzer, S;
Thromb Haemost. 2005; 93(3):544-548
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Severe immune thrombocytopenia due to HPA-1 a host-derived antibodies after non-myeloablative allogeneic hematopoetic stem cell transplantation for multiple myeloma
Macher, S; Schallmoser, K; Staber, P; Neumeister, P; Rosskopf, K; Posch, U; Panzer, S; Lanzer, G
TRANSFUSION. 2005; 45(3): 114A-114A.
Abstracts (Zeitschrift)
A case of neonatal alloimmune thrombocytopenia likely caused by anti-HPA-3a
Schallmoser, K; Kutschera, J; Macher, S; Posch, U; Panzer, S; Lanzer, G
TRANSFUSION. 2005; 45(3): 116A-116A.
Abstracts (Zeitschrift)
Detection of neonatal alloimmune thrombocytopenia (NAIT) by screening of cord blood samples
Schallmoser, K; Macher, S; Walcher, W; Lanzer, G
TRANSFUSION. 2005; 45(3): 116A-117A.
Abstracts (Zeitschrift)
Comparison of platelet concentrates from pooled buffy coats prepared automatically by the OrbiSac system and conventionally produced platelet concentrates
Schallmoser, K; Rosskopf, K; Macher, S; Stubenrauch, M; Lanzer, G
TRANSFUSION. 2005; 45(3): 67A-68A.
Abstracts (Zeitschrift)

2003

Beiträge in Fachzeitschriften

Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations.
Schmoelzer, I; Renner, W; Paulweber, B; Malaimare, L; Iglseder, B; Schmid, P; Schallmoser, K; Wascher, TC;
EUR J CLIN INVEST. 2003; 33(3): 191-198.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Bacterial contamination of pooled platelet concentrates 1999-2001 and after inclusion of predonation sampling in 2002
Wagner, T; Schallmoser, K; Gehrer, M; Bogiatzis, A; Lanzer, G
TRANSFUSION. 2003; 43(9): 49A-50A.
Abstracts (Zeitschrift)

2002

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Clots In cryopreserved autologous peripheral blood stem cell concentrates (Pbsc) at the time of thawing - Possible causes and prophylactic strategies
Rosskopf, K; Wagner, T; Schallmoser, K; Eibl, M; Brezinschek, R; Linkesch, W; Lanzer, G
BONE MARROW TRANSPL. 2002; 29: S203-S203.
Abstracts (Zeitschrift)

2001

Beiträge in Fachzeitschriften

A novel splice-site mutation in intron 7 causes more severe hypercholesterolemia than a combined FH-FDB defect.
deCampo, A; Schallmoser, K; Schmidt, H; Toplak, H; Kostner, GM;
Atherosclerosis. 2001; 157(2): 524-525.
Kurzberichte/Notes

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Feasibility of extracorporal photopheresis in patients after heart transplantation
Gilli, R; Macher, S; Posch, U; Rosskopf, K; Schallmoser, K; Sipurzynski, S; Wagner, T; Wasler, A; Tscheliessnigg, K; Lanzer, G
TRANSFUSION. 2001; 41(9): 43S-43S.
Abstracts (Zeitschrift)
Alloimmunization after RhD-incompatible platelet transfusions
Schallmoser, K; Wagner, T; Rosskopf, K; Macher, S; Posch, U; Gilli, R; Sipurzynski, S; Lanzer, G
TRANSFUSION. 2001; 41(9): 105S-105S.
Abstracts (Zeitschrift)
Association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with cardiovascular risk in type-II diabetes.
Schmoelzer, I; Wascher, TC; Francesconi, M; Francesconi, C; Schmid, P; Schallmoser, K; Renner, W
DIABETOLOGIA. 2001; 44: A312-A312.
Abstracts (Zeitschrift)
Collection efficacy, residual white blood cell count and platelet activation markers: Comparison of MCS LDP C vs. MCS LDP C2
Wagner, T; Schallmoser, K; Vadon, M; Rosskopf, K; Gilli, R; Lanzer, G
TRANSFUSION. 2001; 41(9): 47S-47S.
Abstracts (Zeitschrift)

2000

Beiträge in Fachzeitschriften

Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.
Renner, W; Köppel, H; Brodmann, M; Pabst, E; Schallmoser, K; Toplak, H; Wascher, TC; Pilger, E;
Thromb Haemost. 2000; 83(1): 20-22.
Originalarbeiten (Zeitschrift)
Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.
Renner, W; Köppel, H; Hoffmann, C; Schallmoser, K; Stanger, O; Toplak, H; Wascher, TC; Pilger, E;
Thromb Res. 2000; 99(1):35-39
Originalarbeiten (Zeitschrift)
C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease.
Renner, W; Schallmoser, K; Gallippi, P; Krauss, C; Toplak, H; Wascher, TC; Pilger, E;
Atherosclerosis. 2000; 152(1): 175-179.
Originalarbeiten (Zeitschrift)
Stand der lipidsenkenden Therapie - aktuelle Studien und ihre möglichen Auswirkungen.
Toplak, H; DeCampo, A; Schallmoser, K
Journal für Kardiologie. 2000; 7 (3): 124-128.
Originalarbeiten (Zeitschrift)

1999

Beiträge in Fachzeitschriften

[Evaluation of a newly discovered LDL receptor mutation (exon 10, GAC>AAC, D271N, "FH Graz-1") in familial hypercholesterolemia-- a familystudy].
de Campo, A; Toplak, H; Wascher, TC; Schallmoser, K; Friehs, A; Schmidt, H; Kostner, GM;
Acta Med Austriaca. 1999; 26(1): 20-25.
Originalarbeiten (Zeitschrift)
[Statins--attaining goal values--with reference to recent studies].
Toplak, H; Schallmoser, K; DeCampo, A;
Wien Med Wochenschr. 1999; 149(5-6): 144-145.
Kurzberichte/Notes

1998

Beiträge in Sonstigen Zeitschriften

Hypercholesterinämien
Toplak, H; De Campo, A; Balent, B; Schallmoser, K
Der Mediziner. 1998. 7-8(98): 32-34.

1993

Beiträge in Fachzeitschriften

[Eating behavior of patients with metabolic diseases and metabolically healthy probands in Austria. Results of a questionnaire survey at the Graz Autumn Fair 1991].
Schumacher, M; Eber, B; Schallmoser, K; Toplak, H; Zweiker, R; Lindschinger, M; Sommer, K; Klein, W;
Wien Med Wochenschr. 1993; 143(12):329-332
Originalarbeiten (Zeitschrift)